Restrictions on Access to Abortion Pill Will Be Lifted During Pandemic
TUESDAY, April 13, 2021 -- A requirement that mifepristone abortion pills be dispensed only in person by a medical provider will be put on hold during the COVID-19 pandemic, the U.S. Food and Drug Administration says.
The decision means that health care providers in some states will be able to prescribe mifepristone via telemedicine and mail the pills to patients, CBS News reported.
The American College of Obstetricians and Gynecologists (ACOG) has said the in-person requirement is medically unnecessary and puts patients and medical staff at risk during the pandemic.
In a letter to ACOG, acting FDA Commissioner Janet Woodcock, M.D., cited four medical publications and wrote, "these studies do not appear to show increases in serious safety concerns…occurring with medical abortion as a result of modifying the in-person dispensing requirement during the COVID-19 pandemic," CBS News reported.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Further Support and Information on COVID-19
Read this next
TUESDAY, May 4, 2021 -- Compared with nonphysicians, women physicians delay childbearing, with median age at first childbearing of 32 and 27 years, respectively, according to a...
MONDAY, April 19, 2021 -- Trump-era restrictions on the use of fetal tissue for medical research have been lifted by the Biden administration. The reversal of the restrictions...
WEDNESDAY, April 14, 2021 -- A Trump-era ban on federally funded clinics referring women for abortions will be reversed by the Biden administration, but the process could take...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.